Brief introduction of Zhengzhou Ruipu Eye Hospital

Ruipu medical investment management organization takes the introduction of international advanced medical technology, equipment, talents and management experience as its own responsibility. Ruipu Medical Investment Group, established in 2005, is a chain organization specializing in ophthalmology medical investment and hospital management. Up to now, Puri Group has successfully developed excimer laser to correct more than 95,000 cases of ametropia such as myopia, 43,000 cases of cataract recovery, 3,000 cases of glaucoma, 5,600 cases of strabismus and amblyopia, and handled nearly 80,000 cases of other common and frequently-occurring diseases in ophthalmology. Patients receiving treatment are all over the country, as far away as Europe, America and Southeast Asia.